Feb 28, 2019 | Government, Legislation, MedBen Rx, Rx Costs, Rx Spending, Specialty Drugs
A recent Wall Street Journal editorial warns that government efforts to address prescription drug prices could produce undesirable consequences… and it’s why MedBen Rx believes that market-driven solutions are the preferable method to reducing consumer costs. As...
Feb 12, 2019 | Discounts, MedBen Rx, Pharmacies, Pharmacy Benefits Manager (PBM), Spread Pricing
High-profile health care companies continue to buy each other in an effort to be “biggest and best.” Meanwhile, MedBen continues to grow as it has for over 80 years… by providing clients with superior benefits management services. A quick recap: Anthem Health...
Jan 29, 2019 | Discounts, MedBen Rx, Pharmacies, Pharmacy Benefits Manager (PBM), Rx Costs
A recent high-profile disagreement between Walmart and pharmacy benefits manager (PBM) CVS Caremark exemplifies the friction between pharmacies and PBMs about prescription pricing… and the power that PBMs possess to influence drug costs. MedBen Rx was designed...
Jan 16, 2019 | Average Wholesale Price, Brand Name Drugs, Discounts, Generic Drugs, MedBen Rx, Rx Costs, Rx Spending, Savings
New year, higher drug prices. According to The Wall Street Journal, a representative analysis of major pharmaceutical companies found that the prices of their brand name and generic drugs have risen by an average of 6.3% in 2019 – modest compared to previous years,...
Dec 21, 2018 | Average Wholesale Price, MedBen Rx, Pharmacy Benefits Manager (PBM), Rx Costs, Savings
Drug pricing can be a confusing business… and much of the confusion stems from a drug’s average wholesale price, or AWP. On the surface, the AWP might seem to be… well, the average wholesale price or the average price of a drug. But the price to who? As...
Dec 2, 2018 | Brand Name Drugs, Generic Drugs, MedBen Rx, MedBen Rx Advocate, MedBen Rx Alliance, Pharmacy Benefits Manager (PBM), Specialty Drugs
Modern Healthcare recently highlighted the growing disparity between brand-names and generics in relation to prescription drug spending. A new study finds that while total spending on generic drugs has declined, branded prescription drug spending continues to rise. In...
